Brief: YS Biopharma Board Approves Appointment Of Dave Chenn As Interim CEO

LakeShore Biopharma Co

07/05/2024 23:06

May 7 (Reuters) - YS Biopharma Co Ltd  H6Z.F :
    * YS BIOPHARMA CO LTD:  BOARD APPROVED THE APPOINTMENT OF
DAVE
CHENN AS THE INTERIM CHIEF EXECUTIVE OFFICER OF CO
    * YS BIOPHARMA CO:  APPOINTMENT OF HUI SHAO AS THE CO-CHIEF
EXECUTIVE OFFICER AND CHIEF BUSINESS OFFICER OF CO, EACH
EFFECTIVE ON MAY 2, 2024.

Source text for Eikon:  ID:n0001213900-24-040493 
Further company coverage:  H6Z.F 

 ((Reuters.Briefs@thomsonreuters.com;))